News & Articles

Designed to enrich pathologists' skills in biomarker interpretation and scoring techniques

Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is 70.4% effective when combining data from two dosing regimens

Two different dosing regimens demonstrated efficacy with one showing a better profile

The agreement will allow materials science researchers to benefit from solutions combining HORIBA’s advances in AFM instrumentation with Qnami’s innovation in quantum sensing

The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic

Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported

Non-invasive sample collection and batch processing to test symptomatic and asymptomatic individuals

Internationally renowned Hans Clevers Lab reports using AMSBIO’s CELLBANKER reagent to freeze down their organoids ahead of the COVID-19 spring lockdown

Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide

The kit promises to be a low cost, high-sensitivity diagnostic test for COVID-19 detection

Collaboration to develop next-generation CAR-T cell therapies with improved efficacy and durability